UPDATE 1-AstraZeneca potassium drug delayed by manufacturing snag

LONDON, May 27 (Reuters) - AstraZeneca said on

Friday U.S. regulators would not approve its new drug for high

potassium levels at present due to a manufacturing issue,

dealing a blow to a product...

Read more